Exploring the TAS-120-205 Trial: Understanding FGFR2 Inhibitor Impact on Cholangiocarcinoma Treatment” By Steve|2024-10-13T19:18:56+13:00July 31st, 2024|Categories: All, Drug Reviews, Trials & Studies, Z-Legacy|Tags: 120-205, Clinical Trial, FGFR2, TAS, Tiaho| Read More 0
Unlocking the Power of Immunotherapy and Gem/Cis: A Strategic Battle Plan for Fighting Cholangiocarcinoma By Steve|2024-10-13T19:19:05+13:00July 8th, 2024|Categories: All, Drug Reviews, Trials & Studies, Z-Legacy|Tags: Gem/Cis/Durva, Gem/Cis/Keytruda| Read More 0
Meet Olaparib: A Key Player in the Fight Against Cancer By Steve|2024-10-13T19:19:08+13:00July 2nd, 2024|Categories: All, Drug Reviews, Z-Legacy|Tags: olaparib, PARP Inhibitor| Read More 0